[KAIST GSMSE Young Seok Ju]

첨부문서 : Pre IR_YS Ju.pdf


[Project Leader : Young Seok Ju Organization : KAIST GSMSE]

Research Sector

Genome sequencing, bioinformatic analysis, and validation using organoid models

Research Goal


(e.g., Discovery of new target, Mode of Action, New drug candidate, Drug delivery…)

We whole-genome sequence human tumor and paired normal tissues. Using well-developed bioinformatic analysis pipelines and professional skills, we detect accurate somatic mutations, ranging from point mutations to structural variations, from the cancer genome sequences. Some variants of interests are further validated using in-house organoid models.

Therapeutic Area


Mutations in cancers can be used for prediction of optimal anti-cancer drugs for ptients.

Stage of Research


(e.g., Discovery, validation, scale-up for production…)

Discovery (70%), scale-up for production (30%)

  • Facebook Social Icon

상호 : CHIP KAIST  |  대표 : 신성철
사업자 등록번호 : 314-82-01980  |  개인정보관리책임자 : CHIP KAIST
KAIST 371-1 Guseong-dong, Yuseong-gu, Daejeon, South Korea
PHONE : 042-350-4951 | EMAIL : chipkaist2016@gmail.com